Institute of Sports Medicine, Peking University Third Hospital, Haidian District, Beijing 100191, PR China.
Biomaterials. 2012 Apr;33(12):3375-87. doi: 10.1016/j.biomaterials.2012.01.033. Epub 2012 Feb 7.
Mesenchymal stem cell (MSC) is a promising cell source candidate in tissue engineering (TE) and regenerative medicine. However, the inability to target MSCs in tissues of interest with high efficiency and engraftment has become a significant barrier for MSC-based therapies. The mobilization and transfer of MSCs to defective/damaged sites in tissues or organs in vivo with high efficacy and efficiency has been a major concern. In the present study, we identified a peptide sequence (E7) with seven amino acids through phage display technology, which has a high specific affinity to bone marrow-derived MSCs. Subsequent analysis suggested that the peptide could efficiently interact specifically with MSCs without any species specificity. Thereafter, E7 was covalently conjugated onto polycaprolactone (PCL) electrospun meshes to construct an "MSC-homing device" for the recruitment of MSCs both in vitro and in vivo. The E7-conjugated PCL electrospun meshes were implanted into a cartilage defect site of rat knee joints, combined with a microfracture procedure to mobilize the endogenous MSCs. After 7 d of implantation, immunofluorescence staining showed that the cells grown into the E7-conjugated PCL electrospun meshes yielded a high positive rate for specific MSC surface markers (CD44, CD90, and CD105) compared with those in arginine-glycine-aspartic acid (RGD)-conjugated PCL electrospun meshes (63.67% vs. 3.03%; 59.37% vs. 2.98%; and 61.45% vs. 3.82%, respectively). Furthermore, the percentage of CD68 positive cells in the E7-conjugated PCL electrospun meshes was much lower than that in the RGD-conjugated PCL electrospun meshes (5.57% vs. 53.43%). This result indicates that E7-conjugated PCL electrospun meshes absorb much less inflammatory cells in vivo than RGD-conjugated PCL electrospun meshes. The results of the present study suggest that the identified E7 peptide sequence has a high specific affinity to MSCs. Covalently conjugating this peptide on the synthetic PCL mesh significantly enhanced the MSC recruitment of PCL in vivo. This method provides a wide range of potential applications in TE.
间充质干细胞(MSC)是组织工程(TE)和再生医学中有前途的细胞来源候选物。然而,将 MSC 高效且有效地靶向到感兴趣的组织中仍然是基于 MSC 的治疗方法的一个重大障碍。高效且有效地将 MSC 动员和转移到组织或器官中的缺陷/损伤部位一直是一个主要关注点。在本研究中,我们通过噬菌体展示技术鉴定出一种具有七个氨基酸的肽序列(E7),该肽序列对骨髓来源的 MSC 具有高特异性亲和力。随后的分析表明,该肽可以特异性地与 MSC 高效相互作用,而没有任何种属特异性。此后,E7 被共价偶联到聚己内酯(PCL)电纺网片上,以构建一种“MSC 归巢装置”,用于体外和体内招募 MSC。将 E7 偶联的 PCL 电纺网片植入大鼠膝关节软骨缺损部位,结合微骨折术以动员内源性 MSC。植入 7 天后,免疫荧光染色显示,与 RGD 偶联的 PCL 电纺网片相比,生长到 E7 偶联的 PCL 电纺网片中的细胞对特定的 MSC 表面标志物(CD44、CD90 和 CD105)的阳性率更高(分别为 63.67% vs. 3.03%、59.37% vs. 2.98% 和 61.45% vs. 3.82%)。此外,E7 偶联的 PCL 电纺网片中 CD68 阳性细胞的百分比远低于 RGD 偶联的 PCL 电纺网片中的百分比(5.57% vs. 53.43%)。这一结果表明,E7 偶联的 PCL 电纺网片在体内吸收的炎症细胞明显少于 RGD 偶联的 PCL 电纺网片。本研究结果表明,鉴定出的 E7 肽序列对 MSC 具有高特异性亲和力。将该肽共价偶联到合成的 PCL 网片上可显著增强 PCL 在体内对 MSC 的募集。这种方法为 TE 提供了广泛的潜在应用。